Daniel R. Budman, MD, FACP

Daniel R. Budman, MD, FACP

Co-Executive Director
Northwell Health Cancer Institute

Associate Chief, Division of Hematology-Oncology
North Shore University Hospital

Associate Chief, Division of Hematology-Oncology
Long Island Jewish Medical Center

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

Dr. Budman is one of the leaders of the Northwell Health Cancer Institute. In addition, he is a principal investigator for the Cancer and Leukemia Group B (CALGB), a national clinical research group sponsored by the National Cancer Institute which brings together clinical oncologists and laboratory investigators to develop better treatments for cancer. 

In addition, Dr. Budman previously served as vice chairman of CALGB’s Pharmacology and Experimental Therapeutics Committee for a decade and was responsible for the introduction of new agents into the CALGB breast cancer trials. His major research interests have been the management of breast cancer, experimental therapeutics and clinical pharmacology.

Dr. Budman is professor of medicine at the Zucker School of Medicine.

Dr. Budman received his medical degree from Albert Einstein College of Medicine and completed his internal medicine internship and residency at the Hospital of the University of Pennsylvania, Philadelphia.  In addition, he completed a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center and hematology fellowships at the National Institutes of Health and New York University Medical Center.

View Dr. Budman's clinical profile.

Cancer Institute

Northwell Health Cancer Institute offers cutting-edge treatments and cancer care.